Free Trial

Calumet Specialty Products Partners (CLMT) Expected to Announce Earnings on Friday

Calumet Specialty Products Partners logo with Energy background

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) is expected to be posting its Q1 2025 quarterly earnings results before the market opens on Friday, May 9th. Analysts expect Calumet Specialty Products Partners to post earnings of ($0.28) per share and revenue of $899.62 million for the quarter.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last released its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share for the quarter, beating the consensus estimate of ($1.06) by $0.59. The firm had revenue of $949.50 million during the quarter, compared to analysts' expectations of $921.76 million. The business's revenue for the quarter was down 2.8% on a year-over-year basis. During the same period in the previous year, the business earned ($0.59) earnings per share. On average, analysts expect Calumet Specialty Products Partners to post $-3 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Calumet Specialty Products Partners Price Performance

NASDAQ:CLMT traded up $0.17 during trading hours on Wednesday, reaching $11.35. 768,242 shares of the company traded hands, compared to its average volume of 856,734. The stock has a market cap of $978.45 million, a P/E ratio of -4.11 and a beta of 0.89. The firm's 50-day moving average is $11.24 and its 200-day moving average is $16.73. Calumet Specialty Products Partners has a 1-year low of $7.68 and a 1-year high of $25.29.

Wall Street Analysts Forecast Growth

CLMT has been the topic of several recent research reports. UBS Group upgraded shares of Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and reduced their target price for the company from $15.00 to $12.00 in a report on Monday, March 17th. Wells Fargo & Company lowered their target price on shares of Calumet Specialty Products Partners from $28.00 to $23.00 and set an "overweight" rating for the company in a research note on Wednesday, April 9th. TD Cowen lowered Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and reduced their price objective for the company from $26.00 to $16.00 in a research report on Tuesday, March 4th. The Goldman Sachs Group cut their price target on Calumet Specialty Products Partners from $16.00 to $14.00 and set a "buy" rating on the stock in a report on Wednesday, April 30th. Finally, HC Wainwright restated a "buy" rating and set a $33.00 price target on shares of Calumet Specialty Products Partners in a research report on Monday, March 3rd. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. According to MarketBeat, Calumet Specialty Products Partners presently has a consensus rating of "Hold" and an average target price of $19.60.

Get Our Latest Stock Analysis on Calumet Specialty Products Partners

Insider Buying and Selling

In other news, Director Stephen P. Mawer sold 3,655 shares of the firm's stock in a transaction dated Tuesday, April 22nd. The shares were sold at an average price of $9.29, for a total value of $33,954.95. Following the transaction, the director now owns 283,652 shares of the company's stock, valued at approximately $2,635,127.08. This trade represents a 1.27 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO David Lunin purchased 2,500 shares of the firm's stock in a transaction dated Tuesday, March 4th. The stock was purchased at an average cost of $13.05 per share, with a total value of $32,625.00. Following the acquisition, the chief financial officer now directly owns 2,500 shares in the company, valued at $32,625. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 2.91% of the company's stock.

About Calumet Specialty Products Partners

(Get Free Report)

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Further Reading

Earnings History for Calumet Specialty Products Partners (NASDAQ:CLMT)

Should You Invest $1,000 in Calumet Specialty Products Partners Right Now?

Before you consider Calumet Specialty Products Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.

While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress Is POURING Into This Stock
The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines